Stromal cell-derived factor-1 exerts opposing roles through CXCR4 and CXCR7 in angiotensin II-induced adventitial

Bei Song1, Dongrui Chen2, Zixiong Liu3

  • 1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Stromal cell-derived factor-1 (SDF-1) has opposing roles in hypertension. Blocking SDF-1/CXCR4 worsens vascular remodeling, while blocking CXCR7 improves it, suggesting differential receptor involvement.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Immunology

Background:

  • Hypertension involves vascular adventitia inflammation and immune responses.
  • Stromal cell-derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 are implicated in tissue repair and tumor growth.
  • The role of the SDF-1/CXCR4/CXCR7 axis in hypertensive vascular remodeling remains unclear.

Purpose of the Study:

  • To investigate the involvement of the SDF-1/CXCR4/CXCR7 axis in angiotensin II (AngII)-induced hypertensive vascular remodeling.
  • To elucidate the distinct roles of CXCR4 and CXCR7 in mediating the effects of SDF-1 in the vascular adventitia.

Main Methods:

  • Utilized lentivirus-mediated shRNA to knockdown SDF-1 and CXCR7 in a mouse model of AngII-induced hypertension.
  • Administered CXCR4 antagonist AMD3100 and CXCR7 agonist VUF11207.
  • Examined effects on adventitial thickening, fibrosis, and collagen I deposition in vivo.
  • Assessed inflammation, proliferation, and migration in cultured adventitial fibroblasts (AFs) in vitro.

Main Results:

  • AngII infusion increased SDF-1 expression in the vascular adventitia.
  • Blockade of the SDF-1/CXCR4 axis exacerbated AngII-induced adventitial thickening and fibrosis.
  • CXCR7 knockdown attenuated adventitial remodeling, while CXCR7 activation potentiated it.
  • AMD3100 and VUF11207 aggravated AngII-induced inflammation, proliferation, and migration in cultured AFs.

Conclusions:

  • SDF-1 exerts opposing effects on AngII-induced vascular adventitial remodeling through its receptors CXCR4 and CXCR7.
  • CXCR4 blockade potentiates, while CXCR7 blockade attenuates, hypertensive vascular adventitial remodeling.
  • The SDF-1/CXCR4/CXCR7 axis represents a potential therapeutic target for hypertension-related vascular complications.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
551
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
988